Header Logo

Connection

VIVEK SUBBIAH to Receptor, trkC

Back to Details
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Receptor, trkC.
VIVEK SUBBIAH
Connection Strength
0.794
Receptor, trkC
  1. Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer. Ann Oncol. 2021 06; 32(6):817-819.
    View in: PubMed
    Score: 0.794
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.